5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(3-(isopropylsulfonyl)-1-(4-methoxybenzyl)-1H-pyrazol-4-yl)pyrimidine-2,4-diamine

ID: ALA3787422

Chembl Id: CHEMBL3787422

PubChem CID: 127032502

Max Phase: Preclinical

Molecular Formula: C33H42ClN7O4S

Molecular Weight: 668.26

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Cn2cc(Nc3nc(Nc4cc(C)c(C5CCNCC5)cc4OC(C)C)ncc3Cl)c(S(=O)(=O)C(C)C)n2)cc1

Standard InChI:  InChI=1S/C33H42ClN7O4S/c1-20(2)45-30-16-26(24-11-13-35-14-12-24)22(5)15-28(30)38-33-36-17-27(34)31(39-33)37-29-19-41(40-32(29)46(42,43)21(3)4)18-23-7-9-25(44-6)10-8-23/h7-10,15-17,19-21,24,35H,11-14,18H2,1-6H3,(H2,36,37,38,39)

Standard InChI Key:  WBSZNOLBKNHSNR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3787422

    ---

Associated Targets(Human)

ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 668.26Molecular Weight (Monoisotopic): 667.2708AlogP: 6.62#Rotatable Bonds: 12
Polar Surface Area: 132.29Molecular Species: BASEHBA: 11HBD: 3
#RO5 Violations: 3HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.72CX Basic pKa: 10.33CX LogP: 5.90CX LogD: 3.97
Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.15Np Likeness Score: -1.22

References

1. Zhang P, Dong J, Zhong B, Zhang D, Yuan H, Jin C, Xu X, Li H, Zhou Y, Liang Z, Ji M, Xu T, Song G, Zhang L, Chen G, Meng X, Sun D, Shih J, Zhang R, Hou G, Wang C, Jin Y, Yang Q..  (2016)  Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.,  26  (8): [PMID:26979157] [10.1016/j.bmcl.2016.03.017]

Source